Produkty 63-01-4

CAS 63-01-4 to numer rejestracyjny substancji 16a-Hydroxytestosterone. Oferty producentów: TRC. Dostępne opakowania: 2,5mg.

16a-Hydroxytestosterone
TRC
  • opakowanie: 2,5mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,13S,14S,16R,17R)-16,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 63-01-4) to związek chemiczny o wzorze sumarycznym C19H28O3 i masie molowej 304.4 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,13S,14S,16R,17R)-16,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: YMCWOAZGWMZGQT-FPNLOETNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O3
Masa molowa304.4 g/mol
Nazwa IUPAC(8R,9S,10R,13S,14S,16R,17R)-16,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyYMCWOAZGWMZGQT-FPNLOETNSA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H]([C@@H]4O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 16alpha-Hydroxytestosterone, 16-Hydroxytestosterone, Androst-4-en-3-one, 16,17-dihydroxy-, (16alpha,17beta)-, 16alpha,17beta-Dihydroxy-4-androsten-3-one, 16alpha,17beta-dihydroxyandrost-4-en-3-one, 16a-hydroxytestosterone, Androst-4-en-3-one, 16,17-dihydroxy-, (16.alpha.,17.beta.)-, 16alpha-hydroxy-testosterone, YMCWOAZGWMZGQT-FPNLOETNSA-N, 16a,17b-dihydroxy-4-androsten-3-one
Powiązane formy tego związku
(8R,9S,10R,13S,14S,16S,17R)-16,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
Izomery (ten sam wzór sumaryczny)
methyl 12-oxo-12-phenyldodecanoate C19H28O3
(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C19H28O3
(3R,5R,8S,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-11,17-dione C19H28O3
(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(1R,3bR,5aS,9aS,9bS)-1-(hydroxymethyl)-1,9a-dimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(6R,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C19H28O3
(2R,3bR,5aS,9aS,9bS)-2-hydroxy-1,1,9a-trimethyl-3,3b,4,5,5a,6,9,9b,10,11-decahydro-2H-indeno[4,5-h]isochromen-7-one C19H28O3
(3S,4R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O3
(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-one C19H28O3
(1S,3aS,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,5,5a,6,9,9b,10,11-decahydroindeno[4,5-h]isochromen-7-one C19H28O3